tiprankstipranks
Trending News
More News >

Algorae Pharmaceuticals Sees Revenue Spike but Net Loss

Algorae Pharmaceuticals Sees Revenue Spike but Net Loss

Living Cell Technologies Ltd. (AU:1AI) has released an update.

Confident Investing Starts Here:

Algorae Pharmaceuticals Limited reported a 198% increase in total revenue and other income, rising to $125,200 for the full year ended June 30, 2024, though the company’s net loss marginally improved by 1% to $(2,095,562). The company has not declared any dividends, maintaining a consistent policy from the previous year, and attributes the detailed explanations of the results to the ASX release.

For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1